HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of TRPV1 and ASIC3 in formalin-induced secondary allodynia and hyperalgesia.

AbstractBACKGROUND:
In the present study we determined the role of transient receptor potential V1 channel (TRPV1) and acid-sensing ion channel 3 (ASIC3) in chronic nociception.
METHODS:
1% formalin was used to produce long-lasting secondary allodynia and hyperalgesia in rats. Western blot was used to determine TRPV1 and ASIC3 expression in dorsal root ganglia.
RESULTS:
Peripheral ipsilateral, but not contralateral, pre-treatment (-10min) with the TRPV1 receptor antagonists capsazepine (0.03-0.3μM/paw) and A-784168 (0.01-1μM/paw) prevented 1% formalin-induced secondary mechanical allodynia and hyperalgesia in the ipsilateral and contralateral paws. Likewise, peripheral ipsilateral, but not contralateral, pre-treatment with the non-selective and selective ASIC3 blocker benzamil (0.1-10μM/paw) and APETx2 (0.02-2μM/paw), respectively, prevented 1% formalin-induced secondary mechanical allodynia and hyperalgesia in both paws. Peripheral ipsilateral post-treatment (day 6 after formalin injection) with capsazepine (0.03-0.3μM/paw) and A-784168 (0.01-1μM/paw) reversed 1% formalin-induced secondary mechanical allodynia and hyperalgesia in both paws. In addition, peripheral ipsilateral post-treatment with benzamil (0.1-10μM/paw) and APETx2 (0.02-2μM/paw), respectively, reversed 1% formalin-induced secondary mechanical allodynia and hyperalgesia in both paws. TRPV1 and ASIC3 proteins were expressed in dorsal root ganglion in normal conditions, and 1% formalin injection increased expression of both proteins in this location at 1 and 6 days compared to naive rats.
CONCLUSIONS:
Data suggest that TRPV1 and ASIC3 participate in the development and maintenance of long-lasting secondary allodynia and hyperalgesia induced by formalin in rats. The use of TRPV1 and ASIC3 antagonists by peripheral administration could prove useful to treat chronic pain.
AuthorsVladimir A Martínez-Rojas, Paulino Barragán-Iglesias, Héctor I Rocha-González, Janet Murbartián, Vinicio Granados-Soto
JournalPharmacological reports : PR (Pharmacol Rep) Vol. 66 Issue 6 Pg. 964-71 (Dec 2014) ISSN: 2299-5684 [Electronic] Switzerland
PMID25443722 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
Chemical References
  • 1-(3-(trifluoromethyl)pyridin-2-yl)-N-(4-(trifluoromethylsulfonyl)phenyl)-1,2,3,6-tetrahydropyridine-4-carboxamide
  • APETx2 protein, Anthopleura elegantissima
  • ASIC3 protein, rat
  • Acid Sensing Ion Channels
  • Cnidarian Venoms
  • Pyridines
  • Sulfones
  • TRPV Cation Channels
  • Trpv1 protein, rat
  • benzamil
  • Formaldehyde
  • Amiloride
  • capsazepine
  • Capsaicin
Topics
  • Acid Sensing Ion Channels (genetics, metabolism)
  • Amiloride (administration & dosage, analogs & derivatives, pharmacology)
  • Animals
  • Blotting, Western
  • Capsaicin (administration & dosage, analogs & derivatives, pharmacology)
  • Cnidarian Venoms (administration & dosage, pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Formaldehyde (toxicity)
  • Ganglia, Spinal (metabolism)
  • Hyperalgesia (chemically induced, physiopathology, prevention & control)
  • Pyridines (administration & dosage, pharmacology)
  • Rats
  • Sulfones (administration & dosage, pharmacology)
  • TRPV Cation Channels (genetics, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: